Ország: Kanada
Nyelv: angol
Forrás: Health Canada
CALCIUM GLUCONATE
FRESENIUS KABI CANADA LTD
B05XA19
CALCIUM GLUCONATE
100MG
SOLUTION
CALCIUM GLUCONATE 100MG
INTRAVENOUS
10/50/100/200ML
Ethical
REPLACEMENT PREPARATIONS
Active ingredient group (AIG) number: 0108566002; AHFS:
APPROVED
1998-07-02
Calcium Gluconate Injection, USP 10% - Prescribing Information Page 1 of 9 PRESCRIBING INFORMATION CALCIUM GLUCONATE INJECTION, USP 10% Solution, 100 mg / mL (0.465 mEq / mL) For Intravenous Use Single use vial: 1 000 mg per 10 Single use vial: 5 000 mg per 50 mL Pharmacy bulk package: 10 000 mg per 100 mL ATC Code: B05BB01 Electrolyte Replenisher FRESENIUS KABI CANADA LTD. 165 Galaxy Blvd, Suite 100 Toronto, ON M9W 0C8 Date of Preparation: December 12, 2019 Date of Revision: February 24, 2020 Submission Control No: 229403 Calcium Gluconate Injection, USP 10% - Prescribing Information Page 2 of 9 TABLE OF CONTENTS 1. INDICATIONS .................................................................................................................... 3 2. CONTRAINDICATIONS ................................................................................................... 3 3. DOSAGE AND ADMINISTRATION ............................................................................... 3 3.1 Recommended Dose and Dosage Adjustment ............................................................ 3 3.2 Administration ............................................................................................................. 4 3.3 Reconstitution .............................................................................................................. 5 4. OVERDOSAGE ................................................................................................................... 5 5. DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING .................. 5 6. WARNINGS AND PRECAUTIONS ................................................................................. 6 6.1 Special Populations ..................................................................................................... 7 6.1.1 Pregnant Women ......................................................................................................... 7 6.1.2 Breast-feeding ............................................................................................ Olvassa el a teljes dokumentumot